Besides, Zhao & Cui (2019) also found that two m6A methylation “readers”—YTHDC2 and heterogeneous nuclear ribonucleoprotein C (HNRNPC) could construct a prognostic signature and predict the survival time in HNSCC patients. This evidence concerns the gene YTHDC2 and head and neck squamous cell carcinoma.